Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease

Brain

Volumn 135, Issue 11, 2012, Pages 3348-3354

  Scherfler, Christoph ^a   Seppi, Klaus ^a   Mair, Katherina J ^a   Donnemiller, Eveline ^a   Virgolini, Irene ^a   Wenning, Gregor K ^a   Poewe, Werner ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

dopamine transporter; laterality; Parkinson's disease; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; RADIOLIGAND;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; LEFT HEMISPHERE; MALE; MOTOR DYSFUNCTION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84870170095     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws253     Document Type: Article

References (34)

1. Ashburner J, Andersson JL, Friston KJ. Image registration using a symmetric prior -in three dimensions. Hum Brain Mapp 2000; 9: 212-25.
2. Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, et al. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord 1999; 14: 940-6.
3. Barrett MJ, Wylie SA, Harrison MB, Wooten GF. Handedness and motor symptom asymmetry in Parkinson's disease. J Neurol Neurosurg Psychiatry 2011; 82: 1122-4.
4. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25: 638-43.
5. Keyser De, DeBacker JP, Ebinger G, Vauquelin G. Hydrogen-3-GBR-12935 binding to dopamine uptake sites in the human brain. J Neurochem 1989; 53: 1400-4. (Pubitemid 19267005)
6. de la Fuente-Ferná ndez R, Kishore A, Calne DB, Ruth TJ, Stoessl AJ. Nigrostriatal dopamine system and motor lateralization. Behav Brain Res 2000; 112: 63-8.
7. Djaldetti R, Ziv I, Melamed E. The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol 2006; 5: 796-802.
8. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RS. Spatial registration and normalization of images. Hum Brain Mapp 1995; 3: 165-89.
9. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-52.
10. Glick SD, Ross DA, Hough LB. Lateral asymmetry of neurotransmitters in human brain. Brain Res 1982; 18: 53-63.
11. Guttman M, Stewart D, Hussey D, Wilson A, Houle S, Kish S. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology 2001; 56: 1559-64.
12. Haaxma CA, Helmich RC, Borm GF, Kappelle AC, Horstink MW, Bloem BR. Side of symptom onset affects motor dysfunction in Parkinson's disease. Neuroscience 2010; 170: 1282-5.
13. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
14. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Darqham A, Wallace E, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci 1993; 90: 11965-9. (Pubitemid 24008761)
15. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007; 9: 1533-9. (Pubitemid 47301451)
16. Isaias IU, Benti R, Cilia R, Canesi M, Marotta G, Gerundini P, et al. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset. Neuroreport 2007; 18: 1499-502.
17. Kerenyi L, Ricaurte GA, Schretlen DJ, McCann U, Varga J, Mathews WB, et al. Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol 2003; 60: 1223-9. (Pubitemid 37099627)
18. Kuikka JT, Bergstrom KA, Ahonen A, Lansimies E. The dosimetry of iodine-123 labelled 2 beta-carboxymethoxy-3 beta (4-iodophenyl) tropane. Eur J Nucl Med 1994; 21: 53-6. (Pubitemid 24009664)
19. Laruelle M, Wallace E, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, et al. Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994; 14: 982-94.
20. Marek KL, Seibyl JP, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussel B, et al. [123I]beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996; 46: 231-7.
21. Melamed E, Poewe W. Taking sides: is handedness involved in motor asymmetry of Parkinson's disease? Mov Disord 2012; 27: 171-3.
22. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
23. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, et al. Beta-CIT SPECT demonstrates blockade of 5HTuptake sites by citalopram in the human brain in vivo. J Neural Transm Gen Sect 1995; 100: 247-56.
24. Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005; 64: 208-15.
25. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000; 12: 191-200.
26. Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, et al. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 2005; 128: 1605-12.
27. Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, et al. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995; 38: 589-98.
28. Staley JK, Basile M, Flynn DD, Mash DC. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem 1994; 62: 549-56.
29. Strecker K, Wegner F, Hesse S, Becker GA, Patt M, Meyer PM, et al. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter. J Neurol 2011; 258: 19-26.
30. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease -handedness predicts asymmetry. Neurology 2005; 64: 1925-30.
31. van der Hoorn A, Burger H, Leenders KL, de Jong BM. Handedness correlates with the dominant parkinson side: a systematic review and meta-Analysis. Mov Disord 2011; 27: 206-10. doi: 10.1002/mds.24007.
32. Van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, et al. Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects and hemispheric asymmetries. Am J Geriatr Psychiatry 2002; 10: 36-43.
33. Wagner HN Jr, Burns HD, Dannals RF, Wong DF, Langstrom B, Duelfer T, et al. Imaging dopamine receptors in the human brain by positron tomography. Science 1983; 221: 1264-6. (Pubitemid 13001277)
34. Zijlmans J, Evans A, Fontes F, Katzenschlager R, Gacinovic S, Lees AJ, et al. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease. Mov Disord 2007; 22: 1278-85.